Tag: pneumonia

April 17, 2019

ADMA Biologics Granted US Patent for Treatment and Prevention of Pneumococcal Infections

ADMA Biologics (NASDAQ:ADMA) has announced it has been granted patent no. 10,259,865 from the US Patent and Trademark Office for...
April 5, 2018

Paratek’s New Drug Applications for Oral and Intravenous Omadacycline Accepted for Priority Review by FDA

Paratek Pharmaceuticals (Nasdaq:PRTK) announced today that the U.S. Food and Drug Administration (FDA) has accepted the New Drug Applications (NDAs)...
September 18, 2017

New Data on Nabriva's Pneumonia Drug Sends Share Price Soaring

Nabriva Therapeutics plc saw its stock get a major boost on Monday morning after the company announced top-line results from...
April 12, 2017

Immunovaccine Shows Good Results from Clinical Trial

Immunovaccine provided new data from a Phase I trial testing safety and immunogenicity of its DepoVax-based, small B-cell epitope peptide...
March 28, 2017

Cempra Withdraws Marketing Authorization Application in Europe

Cempra (NASDAQ:CEMP) withdrew its marketing authorization application (MAA) after it realized it would need more data. The application was seeking...
March 27, 2017

Allergan and Paratek Show Positive Results For Acne Treatment

Allergan (NYSE:AGN) and Paratek Pharmaceuticals (NASDAQ:PRTK) announced successful initial results for the two and Phase 3 trials of their acne...
February 22, 2017

Chimerix Announces Final Data from AdVise Trial of Brincidofovir at BMT Tandem Meetings

Chimerix (NASDAQ:CMRX) today announced the presentation of final data from the AdVise trial of brincidofovir for the treatment of adenovirus...